Liana Rosenthal

Title: Liana Rosenthal: Innovator in Parkinson's Disease Research

Introduction

Liana Rosenthal is a prominent inventor based in Lutherville, MD (US). She has made significant contributions to the field of neurodegenerative diseases, particularly in the diagnosis and monitoring of Parkinson's disease (PD). Her innovative work focuses on the detection of Poly(ADP-ribose) (PAR) in the cerebral spinal fluid (CSF) of patients suffering from PD.

Latest Patents

Liana holds a patent for her groundbreaking method titled "Detection of PAR in the CSF of patients with Parkinson's disease." This patent addresses a critical gap in the medical field, as no routine laboratory test has been developed to diagnose, assess, or monitor patients with PD. The method she disclosed allows for the assessment of PAR concentration in the CSF and correlates that concentration to the medical condition of patients with PD. Additionally, her work highlights the potential of PAR as a biomarker for PD.

Career Highlights

Liana Rosenthal is affiliated with The Johns Hopkins University, where she continues her research and development efforts. Her work has the potential to transform the way Parkinson's disease is diagnosed and monitored, providing valuable insights into the condition.

Collaborations

Liana has collaborated with notable colleagues, including Ted M Dawson and Valina L Dawson, who have contributed to her research endeavors.

Conclusion

Liana Rosenthal's innovative approach to detecting PAR in patients with Parkinson's disease represents a significant advancement in the field of neurodegenerative research. Her contributions are paving the way for improved diagnostic methods and better patient care.